Status:

UNKNOWN

Effect of an Amino-Acid-Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms

Lead Sponsor:

Pekarovics, Susan, MD

Conditions:

Fibromyalgia

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of the study is to investigate the effect of the amino acid-based blend on growth hormone levels (measured by IGF-1) and clinical symptoms in individuals with treatment-resistant FM and lo...

Detailed Description

Low hGH levels have been observed in approximately 1/3 of individuals with FM. Low hGH levels are hypothesized to contribute to inadequate treatment outcomes in many individuals with FM and several st...

Eligibility Criteria

Inclusion

  • Have a clinical diagnosis of FM for at least 10 years, poorly controlled FM symptom, and receiving standard of care treatment at the Private Medical Practice of Susan Pekarovics, MD
  • Have low to normal levels of hGH (screening IGF-1 levels between the 15th and 50th percentile for age-appropriate levels)
  • Female participants of childbearing potential will agree to avoid pregnancy during the study.
  • Capable of giving signed informed consent

Exclusion

  • Human growth hormone deficiency (GHD)
  • Individuals with a total score of ≥15 (indicating the presence of moderately severe major depression) or a score of \>0 on Item 9 (suicidal ideation) on the Patient Health Questionnaire-9 (PHQ-9)
  • Pregnant women or women who wish to become pregnant
  • History of substance abuse
  • Previous treatment with recombinant human growth hormone (rhGH)
  • Individuals belonging to the following vulnerable populations: people with disabilities, people who cannot read, educationally disadvantaged, individuals with a serious or life threatening illness, prisoners, non-English speakers, economically disadvantaged individuals, employees of the study sponsor/site.

Key Trial Info

Start Date :

August 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04510181

Start Date

August 1 2020

End Date

July 31 2022

Last Update

August 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Private Medical Practics of Susan Pekarovics, MD

Los Angeles, California, United States, 90048